Anticancer Antibodies Pose Complex Challenges for Drugmakers: An Interview With Martin Van Trieste

Anita T. Shaffer @Shaffer1
Published: Wednesday, Dec 18, 2013
Martin Van Trieste

Martin Van Trieste

Senior Vice President of Quality

at Amgen

As anticancer antibody therapies have evolved into ever more highly engineered and complex structures, so have the manufacturing processes that pave the way for their widespread clinical use.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication